EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

miR-612 Enhances RSL3-Induced Ferroptosis of Hepatocellular Carcinoma Cells via Mevalonate Pathway

Kailin Xing, Xinyu Bian, Dongmin Shi, Shuangshuang Dong, Hongxin Zhou iD, Shuxiu Xiao, Jinjin Bai, Weizhong Wu

Journal of Hepatocellular Carcinoma · 2023-12 · Volume 10 · 2173-2185

DOI: 10.2147/jhc.s433332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2023-12. Verfasst von Kailin Xing und 7 weiteren Autor:innen. Beteiligte Einrichtung: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Shanghai, 200032, People's Republ…. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

FerroptosisHADHAHCCMVA pathwaymiR-612

Autor:innen und Institutionen

  • Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Shanghai, 200032, People's Republic of China.
  • Department of Radiation Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210000, People's Republic of China.
  • Department of Medical Oncology, Shanghai Changzheng Hospital, Shanghai, 200072, People's Republic of China.
  • Clinical Center for Biotherapy, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.

ORCID-Profile: Hongxin Zhou

Zitieren

APA

Xing, K., Bian, X., Shi, D., Dong, S., Zhou, H., Xiao, S., Bai, J., & Wu, W. (2023). miR-612 Enhances RSL3-Induced Ferroptosis of Hepatocellular Carcinoma Cells via Mevalonate Pathway. Journal of Hepatocellular Carcinoma, Volume 10, 2173-2185. https://doi.org/10.2147/jhc.s433332

Vancouver

Xing K, Bian X, Shi D, Dong S, Zhou H, Xiao S, et al. miR-612 Enhances RSL3-Induced Ferroptosis of Hepatocellular Carcinoma Cells via Mevalonate Pathway. Journal of Hepatocellular Carcinoma. 2023;Volume 10:2173-2185. doi:10.2147/jhc.s433332

BibTeX
@article{Xing2023,
  author = {Xing, Kailin and Bian, Xinyu and Shi, Dongmin and Dong, Shuangshuang and Zhou, Hongxin and Xiao, Shuxiu and Bai, Jinjin and Wu, Weizhong},
  title = {miR-612 Enhances RSL3-Induced Ferroptosis of Hepatocellular Carcinoma Cells via Mevalonate Pathway},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2023},
  volume = {Volume 10},
  pages = {2173--2185},
  doi = {10.2147/jhc.s433332}
}
Kostenlos starten →